Development of a second generation anti-Müllerian hormone (AMH) ELISA

Journal of Immunological Methods

Volumn 362, Issue 1-2, 2010, Pages 51-59

  Kumar, Ajay ^a   Kalra, Bhanu ^a   Patel, Amita ^a   McDavid, Lauren ^a   Roudebush, William E ^b  

^a Beckman Coulter Inc   (United States)

^b Beckman Coulter Inc   (United States)

Author keywords

Anti M llerian hormone; Anti M llerian hormone (AMH); Antral follicle count (AFC); Follicle stimulating hormone (FSH); Gametogenesis; In vitro fertilization; In vitro fertilization (IVF); Infertility; Limit of detection (LoD); Limit of quantification (LoQ); M llerian inhibiting substance; M llerian inhibiting substance (MIS); Ovarian hyperstimulation syndrome (OHSS); Ovarian reserve; Tetramethylbenzidine (TMB); Transforming growth factor (TGF )

Indexed keywords

ANTIBODY; BILIRUBIN; HEMOGLOBIN; MUELLERIAN INHIBITING FACTOR; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BINDING AFFINITY; BLOOD SAMPLING; CONTROLLED STUDY; DILUTION; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS; HUMAN; MALE; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN STABILITY; SENSITIVITY AND SPECIFICITY;

ANTI-MULLERIAN HORMONE; CALIBRATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GRANULOSA CELLS; HUMANS; MALE; PROTEIN MULTIMERIZATION; PUBERTY; SENSITIVITY AND SPECIFICITY; TESTIS;

EID: 77958495101     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2010.08.011     Document Type: Article

References (25)

1. Al-Qahtani A., Muttukrishna S., Appasamy M., Johns J., Cranfield M., Visser J.A., Themmen A.P.N., Groome N.P. Development of a sensitive enzyme immunoassay for anti-Mullerian hormone (AMH) and the evaluation of potential clinical applications in males and females. Clin. Endocrinol. 2005, 63(3):267.
2. Baarends W.M., Uilenbroek J.T., Kramer P., Hoogerbrugge J.W., Van Leeuwen E.C., Themmen A.P., Grootegoed J.A. Anti-Mullerian hormone and anti-Mullerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth. Endocrinology 1995, 136:4951.
3. Di Clemente N., Wilson C., Faure E., Boussin L., Carmillo P., Tizard R., Picard J.Y., Vigier B., Josso N., Cate R. Cloning, expression, and alternative splicing of the receptor for anti-Mullerian hormone. Mol. Endocrinol. 1994, 8:1006.
4. Feyereisen E., Mendez Lozano D.H., Taieb J., Hester L., Frydman R., Fanchin R. Anti-Mullerian hormone: clinical insights into a promising biomarker of ovarian follicular status. Reprod. Biomed. Online 2006, 12(6):695.
5. Groome, N.P., Cranfield, M., Themmen, A.P.N., Savjani, G.V., Mehta, K., 2006. Immunological assay and antibodies for anti-Mullerian hormone. US patent 0275850A1.
6. Harlow E., Lane D. Immunoaffinity purification. Antibodies: a Laboratory Manual 1988, 511. Cold Spring Harbour Laboratory Press, New York.
7. Hehenkamp W.J., Looman C.W., Themmen A.P., de Jong F.H., TeVelde E.R., Broekmans F.J. Anti-Mullerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation. J. Clin. Endocrinol. Metab. 2006, 91(10):4057.
8. Hudson P., Douglas I., Donahoe P., Cate R., Epstein J., Pepinsky R.B., MacLaughlin D. An immunoassay to detect human Mullerian inhibiting substance in males and females during normal development 1990, 70:16.
9. Kricka L.J. Human anti-animal antibody interference in immunological assay. Clin. Chem. 1999, 45:942.
10. LaMarca A., Stabile G., Artenisio A.C., Volpe A. Serum anti-Mullerian hormone throughout the human menstrual cycle. Hum. Reprod. 2006, 21(12):3103.
11. LaMarca A., Giulini S., Tirelli A., Bertucci E., Marsella T., Xella S., Volpe A. Anti-Mullerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology. Hum. Reprod. 2007, 22(3):766.
12. Lee M., Donahoe P. Mullerian inhibiting substance: a gonadal hormone with multiple functions. Endocr. Rev. 1993, 142:152.
13. Lee M., Donahoe P., Hasegawa T., Silverman B., Crist G., Best S., Hasegawa Y., Noto R., Schoenfeld D., MacLaughlin D. Mullerian inhibiting substance in human: normal levels from infancy to adulthood. J. Clin. Endocrinol. Metab. 1996, 81:571.
14. Lee M., Misra M., Donahoe P., MacLaughlin D. MIS/AMH in the assessment of cryptorchidism and intersex conditions. Mol. Cell. Endocrinol. 2003, 211:91.
15. Long W.Q., Ranchin V., Pautier P., Belville C., Denizot P., Cailla H., Lhomme C., Picard J.Y., Bidart J.M., Rey R. Detection of minimal levels of serum anti Mullerian hormone during follow-up of patients with ovarian granulose cell tumor by means of a highly sensitive enzyme-linked immunosorbent assay. J. Clin. Endocrinol. Metab. 2000, 85:540.
16. Muttukrishna S., McGarrigle H., Wakim R., Khadum I., Ranieri D.M., Serhal P. Antral follicle count, anti mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology?. BJOG 2005, 112(10):1384.
17. National Committee for Clinical Laboratory Standards Evaluation of the Linearity of Quantitative Analytical Methods; Proposed Guideline EP-6 1986, NCCLS, Wayne, PA.
18. National Committee for Clinical Laboratory Standards Interference Testing in Clinical Chemistry; Proposed Guideline EP7-P 1986, NCCLS, Wayne, PA.
19. National Committee for Clinical Laboratory Standards Method Comparison and Bias Estimation using Patient Samples; Approved Guideline EP9-A 1995, NCCLS, Wayne, PA.
20. National Committee for Clinical Laboratory Standards Evaluation of Precision Performance of Clinical Chemistry Devices; Approved Guideline EP5-A 1999, NCCLS, Wayne, PA.
21. National Committee for Clinical Laboratory Standards Protocol for determination of limits of detection and limits of quantitation; Approved Guideline EP17-A, 664, V0l 24 No 34 2004, NCCLS, Wayne, PA.
22. Picard J.Y., Benaroust R., Guerrier D., Josso N., Khan A. Cloning and expression of cDNA for anti-Mullerian hormone. Proc. Natl. Acad. Sci. 1986, 83:5464.
23. Picon R. Action du testicule foetal sur le de- velopment in vitro des canaux de Muller ches let rat. Arch. Anat. Microsc. Morphol. Exp. 1969, 58:1.
24. Teixeira J., Maheswaran S., Donahoe P.K. Mullerian inhibiting substance: an instructive developmental hormone with diagnostic and possible therapeutic applications. Endocr. Rev. 2001, 22:657.
25. Wilson C., Clemente N., Ehrenfels C., Pepinsky R., Josso N., Vigier B., Cate R. Mullerian inhibiting substance requires its N-terminal domain for maintenance of biological activity, a novel finding within the transforming growth-factor-beta superfamily. Mol. Endocrinol. 1993, 7:247.